Vitamin A: Yet another player in multiple sclerosis pathogenesis?

Expert Review of Clinical Immunology

Volumn 9, Issue 2, 2013, Pages 113-115

  Filippi, Massimo ^a   Preziosa, Paolo ^a   Rocca, Maria A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

interferon; MRI; multiple sclerosis; relapse; retinol

Indexed keywords

BETA1A INTERFERON; RETINOL; VITAMIN D;

ARTICLE; CLINICAL EVALUATION; DISEASE ACTIVITY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; IMMUNOMODULATION; METABOLITE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; VITAMIN BLOOD LEVEL;

EID: 84873589190     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.105     Document Type: Article

References (15)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N. Engl. J. Med. 343(13), 938-952 (2000
2. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat. Rev. Immunol. 8(9), 685-698 (2008
3. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. Lancet Neurol. 9(7), 727-739 (2010
4. Summerday NM, Brown SJ, Allington DR, Rivey MP. Vitamin D and multiple sclerosis: Review of a possible association. J. Pharm. Pract. 25(1), 75-84 (2012
5. Mowry EM, Waubant E, McCulloch CE et al. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann. Neurol. 72(2), 234-240 (2012
6. Besler HT, Comoglu S, Okçu Z. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr. Neurosci. 5(3), 215-220 (2002
7. Royal W 3rd, Gartner S, Gajewski CD. Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis. Mult. Scler. 8(6), 452-458 (2002
8. Løken-Amsrud KI, Myhr KM, Bakke SJ et al. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult. Scler. doi:10.1177/1352458512457843 (2012) (Epub ahead of print
9. Torkildsen O, Wergeland S, Bakke S et al. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): A randomized, double-blind, placebo-controlled trial. Arch. Neurol. 69(8), 1044-1051 (2012
10. Ramagopalan SV, Maugeri NJ, Handunnetthi L et al Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1.*1501 is regulated by vitamin D. PLoS Genet. 5(2), e1000369 (2009
11. Filippi M, Rocca MA, De Stefano N et al. Magnetic resonance techniques in multiple sclerosis: The present and the future. Arch. Neurol. 68(12), 1514-1520 (2011
12. Barkhof F, Simon JH, Fazekas F et al. MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nat. Rev. Neurol. 8(1), 13-21 (2012
13. Filippi M, Rocca MA. MR imaging of multiple sclerosis. Radiology 259(3), 659-681 (2011
14. Qu ZX, Dayal A, Jensen MA, Arnason BG. All-trans retinoic acid potentiates the ability of interferon β-1b to augment suppressor cell function in multiple sclerosis. Arch. Neurol. 55(3), 315-321 (1998
15. Qu ZX, Pliskin N, Jensen MW, White D, Arnason BG. Etretinate augments interferon β-1b effects on suppressor cells in multiple sclerosis. Arch. Neurol. 58(1), 87-90 (2001)